1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Vieworks Co., Ltd

Vieworks Co., Ltd

KKRX:100120
27,750.00
KRW
-100.00
(-0.36%)
3,134.59EPS
8.37P/E
234.50BMarket Cap
Nov 11Next Earn
Vieworks Co., Ltd
KRX:100120
(Korea Stock Exchange)

Recent

price

27,750.00

P/E

ratio

8.37

div

yld

2.49%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
3,247.77
3,582.9
4,678.68
6,646.04
7,081.44
9,340.03
11,743.59
12,395.62
13,253.49
13,799.59
16,766.03
20,627.19
25,909.95
23,993.8
24,271.6
26,513.98
27,113.74
Revenue per Share
782.67
674.56
566
946
1,048
1,589
2,701
1,971
2,095
2,457
2,395
3,575
2,890
1,603
2,319
2,434
3,254.44
Basic EPS, GAAP
-112.83
-126.55
242.33
250.92
-897.47
1,536.14
1,593.27
1,433.22
1,826.02
943.74
-1,821.62
1,064.92
-1,794.04
882.85
720.63
862.52
1,976.75
Free Cash Flow per Basic Share
65.39
66.2
99.95
99.96
100.02
99.98
100
200.36
200.46
299.97
412.39
454.1
749.92
700.19
349.94
610.31
690.4
Dividend per Share
4,319.15
4,880.49
5,332.13
6,184.33
7,068.45
8,469.07
11,058.32
12,696
14,287
16,379.06
18,018.77
20,478.94
22,784.17
23,482.27
25,807.22
29,006.22
28,341.64
Book Value per Share
3,501.62
3,663.18
4,176.34
5,203.64
6,351.87
7,991.58
10,759.42
12,379.32
13,669.01
15,729.32
17,342.56
19,810.13
22,044.6
22,423.65
24,895.02
28,101.6
27,442.81
Tangible Book Value per Share
9
10
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
Basic Weighted Avg Shares
30,497
35,629
46,821
66,501
70,811
93,439
117,303
123,461
131,404
136,010
160,264
193,139
237,929
220,251
222,898
239,335
243,106
Sales/Revenue/Turnover
25.03
22.03
16.03
19.28
18.72
19.67
25.97
23.19
17.17
19.43
18.14
18.02
18.35
8.51
10.02
8.95
11.6
Operating Margin (%)
1,223
1,353
2,675
3,054
3,457
3,627
3,513
3,727
3,113
3,451
3,855
5,526
6,123
6,990
7,438
8,328
8,494
Depreciation Expense
7,349
6,708
5,664
9,466
10,480
15,897
26,979
19,631
20,771
24,216
22,893
33,474
26,539
14,715
21,297
21,971
29,180
Net Income, GAAP
12.28
16.1
16.93
22.68
16.16
17.55
19.48
15.61
17.24
19.36
17.95
15.42
19.96
11.56
17.61
17.48
16.19
Effective Tax Rate (%)
24.1
18.83
12.1
14.23
14.8
17.01
23
15.9
15.81
17.8
14.28
17.33
11.15
6.68
9.55
9.18
12
Profit Margin (%)
26,248
29,394
33,112
39,742
36,525
52,542
75,477
87,900
93,312
107,529
93,245
107,124
113,314
112,266
124,466
94,004
90,303
Working Capital
- -
- -
- -
7,200
2,400
1,500
300
- -
- -
200
115
678
620
998
21,008
2,324
2,254
LT Debt
42,649
49,202
53,600
61,953
70,895
84,689
110,383
126,082
140,748
161,454
170,588
188,234
209,319
215,645
236,797
248,674
242,735
Total Equity
17.25
13.16
11.99
15.83
14.87
17.98
23.63
19.64
13.76
13.74
13.69
14.85
14.65
6.36
6.67
5.84
7.7
Return on Invested Capital (%)
19
14.78
11.37
15.49
14.27
19.37
27.15
16.48
15.54
15.85
13.34
17.34
11.66
6.37
8.31
7.89
10.29
Return on Capital (%)
19
14.67
11.09
16.44
15.81
20.47
27.68
16.6
15.56
16.03
13.8
18.69
13.36
6.93
9.41
9.03
12.25
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
81,202
67,673
69,343
LT Borrowings
233
203
172
LT Finance Leases
2,244
2,120
2,082
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
177,455
168,752
234,497

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
195,627
189,692
195,585
Cash, Cash Equivalents & STI
65,349
57,044
56,827
Accounts Receivable, Net
45,172
53,634
55,381
Inventories
75,008
69,266
74,070
Total Current Liabilities
105,654
95,687
105,282
Payables & Accruals
- -
- -
- -
ST Debt
81,202
67,673
69,343
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.6%
7.88%
5.02%
Free Cash Flow
-88.81%
-114.47%
17.65%
Net Income, GAAP
8.83%
5.77%
3.17%
Sales/Revenue/Turnover
10.34%
8.97%
7.37%
Total Cash Common Dividend
26.59%
16.92%
71.43%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
60,549
54,224
48,378
59,747
222,898
2025
54,397
62,704
53,673
68,560
239,335
2026
58,169
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
881
292
140
1,006.05
2,319
2025
255
237.11
742.8
1,207.76
2,434
2026
1,069.55
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
350.1
- -
- -
- -
349.94
2025
600.61
- -
- -
- -
610.31
2026
693.43
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
Medtronic plc. (NYSE:MDT)
Business
Vieworks Co., Ltd. specializes in the advancement, production, and distribution of sophisticated imaging technology and integrated solutions. The company provides a comprehensive range of digital X-ray detectors and associated image processing software, catering to diverse needs such as general medical radiography, dental procedures, surgical C-arms, fluoroscopy, mammography, and veterinary applications. Additionally, Vieworks manufactures high-performance industrial cameras, which are critical for precision tasks like industrial inspection, semiconductor and flat panel display examination, and aerial imaging. Its portfolio also includes bio-imaging systems for preclinical research and digital pathology, offered under the VISQUE brand. Founded in 1999, the enterprise is headquartered in Anyang-si, South Korea.